ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Cancer Complications

Cancer Complications

In patients with HER2-positive breast cancer undergoing trastuzumab therapy, the use of an ACE inhibitor or beta-blocker could protect against cardiac toxicity.

We review here the recommendations of the American Society of Clinical Oncology, as well as some new and promising approaches to neuropathy, including new neuromodulation techniques.

Chemotherapy-induced peripheral neuropathy is a serious yet common side effect of cancer treatment. This devastating complication, which typically manifests as tingling and numbness in the hands and feet, has an enormous influence on patients’ quality of life.

Despite evolution of treatments and substantial improvements in survival, the self-reported health status among adult survivors of childhood cancers has not improved over 3 decades.

Stratifying breast cancer patients by chemotherapy and genetic susceptibility, researchers were able to identify patients at high risk of venous thromboembolism.

A cognitive rehabilitation program known as Insight resulted in improvements in cognitive symptoms compared to standard care in adult cancer survivors.

In patients with HER2-positive breast cancer undergoing trastuzumab therapy, elevated troponin I or T before the treatment is associated with an increased risk of trastuzumab-related cardiac dysfunction.

Pages

Subscribe to Cancer Complications on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.